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Since the 15th or 16th century compound tincture of benzoin has been used
extensively to treat wounds, ulcers, fissures of the nipples, lips and anus, and
similar conditions (1, 2). For these purposes, the tincture was, and is, used as a
balsam under different names (Balsam Traumatic, "baume de commandeur")
and was incorporated in plasters ("court plaster") (3). Today, it is common
practice, in conditions requiring large adhesive tape dressings, to paint the
tincture on the entire skin area to be covered by the tape, because the tincture
increases the tackiness of the tape. Compound tincture of benzoin is often added
to water and glycerin in preparing steam inhalations for bronchitis, asthma, and
other respiratory affections (2).
In view of the fact that the tincture contains a number of compounds of plant
origin, the occurrence of skin irritations from it might be expected. A search of
the literature, however, revealed oniy one report of a dermatitis produced by
compound tincture of benzoin. James (4) recorded an instance in a 27 year old
man who applied the tincture to abrasions of the right hand, and about 12 hours
later developed an extensive, acute vesiculo-bullous dermatitis of the hand, and
of the entire face. A patch test with compound tincture of benzoin was strongly
positive. The author stated that neither he nor any of his colleagues had en-
countered another case of "susceptibility" to compound tincture of benzoin,
although it has been used "in thousands of patients."
In accord with this statement are the recommendations for the use of com-
pound tincture of benzoin, either as a "balsam" or in ointments, by surgeons,
and by dermatologists as recently as 1946 (5). The rarity of dermatitis due to
compound tincture of benzoin is further attested to by the fact that this substance
is not included among the testing materials listed by Rostenberg, Jr. and Sulz-
berger (6) in studies of eczematous contact-type dermatitis.
The paucity of reports of eczematous contact-type dermatitis from compound
tincture of benzoin, and the observation of three such cases in one hospital within
little more than a year, prompted us to make the present report.
REPORT OF CASES
Case 1. A 22 year old white female nurse was admitted to the hospital on April 17, 1947.
About 14 days prior to admission adhesive tape strapping had been applied to the right
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ankle because of a swelling that followed a meniscus operation; the skin had first been
painted with compound tincture of benzoin. Four days later the strapping was removed,
and three to four days after this the patient was vaccinated against smallpox. The next
morning, about 18 hours after the vaccination, there developed a severe itching eruption of
the right ankle and foot. Of significance in the past history was the fact that, from the age
of 9 to 16 years, the patient had had attacks of poison ivy dermatitis annually.
On admission, there was noted on the dorsum of the right foot and the lower third of the
leg a diffuse, erythematous, edematous, somewhat papular dermatitis, the contours of which
corresponded to the taped area. In some places the dermatitis extended beyond the area
previously covered by the tape.
In the first four or five days after admission the dermatitis became worse, in spite of treat-
ment by bed rest, continuous cold packs with dilute Burow's solution, 50 mg. of Pyriben-
zamine orally every four hours, and calcium gluconate, 10 cc. of a 10 per cent solution intra-
venously daily. The eruption extended up the right leg to the inner surfaces of both thighs,
and later there appeared an erythematous, patchy and coalescent dermatitis of the chin,
the cheeks, and the back. On the left foot, particularly on its inner aspect, a dermatitis
resembling erythema multiforme developed. The original site on the right foot and ankle
showed extensive vesiculation, and formation of bullae, largely at the margins of the
affected area.
During the next week, the dermatitis receded, although the bullae on the right foot and
ankle were somewhat resistant, refilling repeatedly after sterile aspirations. Finally, on
April 29, 1947, 12 days after admission, the dermatitis had subsided sufficiently to permit
application of patch tests.
Patch tests were performed with adhesive tape, with compound tincture of benzoin, and
with the tincture covered by adhesive tape. The adhesive tape alone elicited no reaction,
while the two tests with the tincture showed diffuse erythema and edema after 24 hours.
Case 2. A 50 year old white female nurse was admitted to the hospital on May 21, 1948,
because of back pain due to an injury, and on May 22, 1948, an adhesive tape strapping was
applied to the lumbar area encircling the lower trunk. Compound tincture of benzoin was
used under the strapping. Two days later, heat (diathermy) treatments of the painful region
were started.
On June 1, 1948, nine days after the application of the strappings, a dermatitis of the in-
volved skin area was noted, and the tape was removed and the skin cleansed with ether.
The dermatitis was moderately severe and diffuse, consisting of coalescent erythematous
papules and occasional vesicles. It cleared up with bland treatment within a few days. Patch
tests with compound tincture of benzoin alone and the tincture covered with adhesive gave
a 2-plus delayed (72 hour) reaction; the patch test with adhesive alone was negative.
On June 16, 1948, the patient inhaled compound tincture of benzoin because of a "sore
throat." The next day she developed a pruritic skin rash, and frontal headache. This erup-
tion was not observed by the authors, and it had almost completely subsided two days later
when the patient was seen by another physician. The patient stated that she had used in-
halations of compound tincture of benzoin for many years.
The patient gave a history of poison ivy dermatitis, and of "intolerance" to ephedrine
nose drops.
Case3. A 28 year old white male student was admitted to the hospital on September 1,
1948, for emergency operation of acute appendicitis. After the operation, the incision was
covered by gauze dressings, and the surrounding skin was painted with compound tincture
of benzoin over which adhesive tape was applied. This benzoin-tape dressing covered a
large portion of the lower abdomen and inguinal regions on both sides. On the second or
third day after the operation pruritus developed under the dressing and a dermatitis was
noted.
The patient was seen by the dermatologist on September 10, 1948. An extensive dermatitis
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was present in the entire area of the benzoin-tape dressing on the lower abdomen and groins;
the skin in the vicinity of the incision, where benzoin and adhesive had not been applied,
was normal. The outlines of the dermatitis conformed almost exactly to the shape of the
dressing. The affected skin was diffusely edematous, red, weeping, and very pruritic. The
hands showed slight diffuse edema and some erythematous mottling.
On questioning, the patient recalled that he had had a dermatitis from adhesive tape
used for strapping a sprain of the back in 1943. He thought that compound tincture of ben-
zoin had been used at that time, but he did not remember other contacts with the drug.
The patient also recalled having had attacks of poison ivy dermatitis in the past.
Cold compresses of boric acid solution, applications of a zinc oxide emulsion, and oral
Pyribenzamine resulted in rapid improvement of the dermatitis.
On September 14, 1948 patch tests were performed with adhesive tape, compound tincture
of benzoin, and a combination of the tincture and tape. These patch tests showed a 4-plus
reaction to compound tincture of benzoin, a 3-plus reaction to the combination of benzoin
and tape, and a negative reaction to tape alone. The reactions were eczematous, well de-
veloped after 24 hours, and even more pronounced two days later; there was no spread be-
yond the patch areas, and there was no focal flare-up.
DERIVATION AND COMPOSITION OF COMPOUND TINCTURE OF BENZOIN





Alcohol, 95% q.s. ad 1000.0
Benzoin is a "balsamic oleoresin," i.e. a mixture ofresin and volatile (essential)
oil containing bensoic or cinnamic acid and/or their esters. Benzoin contains
both benzoic and cinnamic acid, as well as esters of cinnamic acid (Styrol and
Styracin). Vanillin (3-methoxy-4-hydroxy-benzaldehyde, C8H8O,) is also present
in benzoin. Benzoin is derived from plants of the Family Styraceae (Styrax
Benzoin Dryander-"Sumatra Benzoin," or Styrax Benzoin Tonkinensis, or other
species such as "Siam Benzoin").
Storax (Styrax) contains free cinnamic acid and a number of cinnamic acid
esters (Styracin, Storesin, Styrol, and others), as well as volatile oils, resins, and
traces of vanillin. Unlike benzoin, storax does not contain benzoic acid or its
esters, but it is nevertheless a balsamic oleoresin. The "sweet oriental gum", as
styrax is incorrectly' called, comes from the trunk of Liquidamber orientalis
Miller ("Levant Storax") or Liquidamber styraciflua Linné ("American Storax").
These plants belong to the Family Hamamelidaceae.
Tolu Balsam, like benzoin, contains both benzoic and cinnamic acids and
esters of these acids, resins, and volatile oils. Tom is, therefore, a true balsamic
oleoresin. It differs from benzoin in that it does not contain vanillin. This balsam
is obtained from a plant of the Family Leguminosae, Toluifera (Myroxylon)
Balsamum Linné.
Aloes is an oleoresin containing resins, volatile oils, aloin, and emodin. Emodin
'A gum is chemically a carbohydrate of the formula C, H,, 0,, related to starch and
cellulose, not soluble as are resins in alcohol, but soluble or jelly-forming in water.
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is an anthraquinone (4,5, 7-Trthydroxy-2-methylanthraquinone), and aloin is a
glucoside that yields emodin and other active anthraquinones on cleavage. The
aloe plant belongs to the Family Liliaceae, and aloes is the inspissated juice of
the leaves of Aloe Perryi Baker ("Socotrine Aloe"), or Aloe vera Linné ("Curacao
Aloe"), and less often of other varieties of aloes.
Table 1 gives a simplified schema of the composition of the four basic constitu-
ents of compound tincture of benzoin. The balsam of Peru is included in the
table because it was also used in testing. This was done because balsam of Peru
is, like benzoin, storax, and tolu, a balsamic oleoresin, i.e. it contains resins and
volatile oils combined with benzoic and cinnamic acid and esters of these acids.
Vanillin is also present as in benzoin and storax. It is derived from a plant be-
longing to the same Family of Leguminosae that produces tolu: Toluifera (My-
roxylon) Pereirae (Royle), Bail. Because of its composition it was thought pos-
sible that patch test results with balsam of Peru might contribute to the discovery
TABLE 1
Derivation and composition of constituents of compound tincture of benzoin, balsam of Peru,
and Rhus toxicodendron







s N;CACIDANDESTERS VAN-LIL IN
+ 0
o
0Benzoin Styraeeae Bark; wood + + + +
Storax Hamamelidaceae Bark; wood + + 0 + + 0 0
Tolu Leguminosae Bark; wood;
leaves
+ + + + 0 0 0
Aloes Liliaceae Leaves + + 0 0 0 + 0
Peru Leguminosae Bark; wood + + + + + 0 0
Rhus Anacardiaceae Leaves + + 0 0 0 0 +
of the specific substance responsible for the dermatitides from compound tinc-
ture of benzoin.
Rhus toxicodendron is shown in the table because all three patients had
suffered from prior attacks of poison ivy dermatitis. This may be no more than
coincidence in view of the fact that the dermatitis-producing principle of Rhus
has been identified as urushiol (3-Pentadecadienyl catechol) (7) which is not
known to be present in any of the constituents of compound tincture of benzoin.
Volatile oils are mixtures of terpenes (aromatic hydrocarbons), phenols,
ketones, aldehydes, and acids. Some also contain nitrogen (usually as cyanides),
or sulphur.
METHODS AND RESULTS OF PATCH TESTS
In order to determine unequivocally the specific substance responsible for
the dermatitis due to compound tincture of benzoin, it would have been necessary
to test with the various resins and volatile oils, and with benzoic acid, cinnamic
acid, vanillin, aloin, and emodin. This was impracticable for several reasons,
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but principally because it was impossible to obtain the necessary materials on
short notice.
In table 2 are shown the results of the actual tests performed. All three patients
were tested grossly, that is with adhesive plaster alone, with compound tincture
of benzoin, and with the tincture covered by adhesive. More detailed tests could
be carried out in only two patients, Cases 2 and 3. These tests were performed
with the ingredients of compound tincture of benzoin in their official concentra-
tion, that is 10 per cent tincture of benzoin, 4 per cent tincture of tolu, 8 per cent
cent tincture of storax, and 2 per cent tincture of aloes. Tests were also made
with 6 per cent benzoic acid in petrolatum, 5 per cent cinnamic acid in petrolatum,
10 per cent vanillin in petrolatum, and 10 per cent balsam of Peru in petrolatum;
these are the recommended vehicles and concentrations (6).
TABLE 2
Patch test results in three patients with dermatitis venenata due to compound tincture of benzoin
SUBSTANCE CASE 1 CASE 2 CASE 3
Adhesive tape 0 0 0
Compound tincture of benzoin + + +
Compound tincture of benzoin covered by adhesive
tape + + +
Benzoin, tincture (10%) nd. + ++++
Tolu, tincture (4%) n.d. + ++++
Storax, tincture (8%) n.d. ++ +++
Aloes, tincture (2%) n.d. ++ ++
Bensoic acid, 6% in petrolatum n.d. + 0
Cinnamic acid, 5% in petrolatum nd. 0 ++
Vanillin, 10% in petrolatum n.d. 0 0
Balsam of Peru, 10% in petrolatum nd. 0 +++
0 = negative. + = positive. nd. = not done.
All three patients gave negative reactions with adhesive tape alone, and posi-
tive reactions with the compound tincture of benzoin alone and the compound
tincture covered by adhesive.
In the two patients tested (Cases 2 and 3), positive reactions were obtained
with the four basic tinctures (benzoin, tolu, storax, and aloes) although the re-
actions were much more violent in Case 3. Because of the comparative weakness
of the reactions in Case 2, the tests were repeated simulating the original condi-
tions, that is the four tinctures were painted on the skin and covered with ad-
hesive tape. This procedure resulted in somewhat stronger reactions, as recorded
in table 2, but still weak in comparison with those in Case 3. It should be noted
that adhesive tape controls were repeated simultaneously and these were nega-
tive. It may be that maceration of the skin by the adhesive tape and the heat
applied to the area contributed to the production of the dermatitis.
Of the break-down products, benzoic acid gave a i-plus reaction in Case 2,
and cinnamic acid a 2-plus reaction in Case 3. Yanillin was negative in both pa-
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tients. The 3-plus reaction to balsam of Peru in Case 3 was not surprising in view
of the chemical similarity of this balsam and the other balsams; more surprising
was the fact that it elicited no reaction in Case 2.
It would appear, therefore, from the results obtained in these cases that no
single constituent of compound tincture of benzoin was responsible for the
dermatitis, but that all of the components seemed able to produce an eruption
in these individuals.
In view of these results, it was decided to do patch tests with the compound
tincture of benzoin and its constituents in two control groups. Group A
consisted of 10 ward patients with various skin diseases and Group B of 20 ward
patients with non-allergic conditions and without skin disease ("normals"). In
these two groups tests were first carried out with compound tincture of benzoin
alone by the standard method. In the 20 "normal" patients in Group B not a
single positive reaction was obtained to either the first application or to repeated
application (after a "sensitization period" of two weeks).
TABLE 3












oDermatophytosis ++ +++ ++ + ++
Dermatitis venenata ++ +± ++ + +++ n.d. n.d. n.d.
* After 48 hours; the other results after 24 hours.
+ = positive. 0 = negative. n.d. = not done.
Group A comprised 10 patients: Three had dermatitis venenata, two atopic
dermatitis, and one each had infectious eczematoid dermatitis, dermatophytosis
and dermatophytid, sycosis vulgaris, discoid lupus erythematosus, and pruritus
ani. They were tested in the same manner as the Group B patients and eight of
the ten gave negative reactions on first and second testing. However, one patient
with dermatitis venenata and one with dermatophytosis and dermatophytid gave
negative reactions to the first test and positive reactions to the second test, as
shown in table 3.
As in the two patients with spontaneous dermatitis from compound tincture of
benzoin the positive reactions in the two deliberately sensitized patients were not
specific to a single component of the compound tincture.
COMMENT
The results of the detailed patch tests in the four sensitized patients (two spon-
taneously sensitized and two deliberately sensitized) were consistent in two re-
spects: Positive reactions were obtained with the four basic ingredients of the
compound tincture of benzoin (benzoin, tolu, storax, and aloes), and negative
reactions were obtained with vanillin. The reactions with the acids varied widely:
One patient reacted only to benzoic acid; one reacted only to cinnamic acid; one
reacted to both benzoic and cinnamic acids.
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Several plausible explanations suggest themselves for the patch test behavior:
(1) The sensitizing substance differs, being benzoic acid in one patient, cinnamic
acid in the second, and both acids in the third. (2) The reactions to the acids are
incidental, and the actual sensitizing substance is either the resin or the volatile
oil, or both. (3) The sensitization is not due to the acids, the resins, or volatile
oils per se, but to some common breakdown product of one or more of these sub-
stances.
While we were unable to confirm this by differential patch testing, we believe
the best explanation of the findings in our cases is that the dermatitis was pro-
duced by the resins or volatile oils. Much investigation has been carried out on
dermatitis due to natural resins and volatile oils (rhus, cinnamon, cassia, lemon,
Dammar resin, rosin, etc.) (8) and a number of allergenic substances have been
determined. However, no one has as yet demonstrated the presence of a common
allergenic substance in natural plant resins and volatile oils. In at least one in-
stance, a case of dermatitis due to aloes, the specific sensitizing agent was found
to be emodin rather than the resin or the volatile oil (9).
The history of rhus dermatitis in the three spontaneous cases invites
the assumption of possible cross-sensitivity between rhus and compound tincture
of benzoin. This is difficult to believe because it is known that the sensitizing
agent in rhus is a catechol derivative, urushiol, that is not present in any of the
ingredients of compound tincture of benzoin (10); and also because there were no
initial reactions to compound tincture of benzoin among the thirty control pa-
tients. On the basis of published studies (11), one would expect an incidence of
cutaneous sensitivity to rhus of about 40 per cent in adults. If the basic assump-
tion of cross-sensitivity between rhus and benzoin were correct, it follows that
some ten or twelve members of the control group should have reacted positively
to the initial application of the compound tincture of benzoin. The speculations
that certain of the resins or volatile oils in compound tincture of benzoin may be
oxidized to catechols homologous to urushiol, or that the constituents of com-
pound tincture of benzoin and urushiol are converted to a common final allergen,
require further study.
The practical significance of benzoin dermatitis should not be overestimated.
The fact that twenty "normals" could not be readily sensitized to compound tinc-
ture of benzoin is in agreement with the almost complete lack of reports on der-
matitis from this substance. Admittedly, twenty controls are insufficient; how-
ever, an inquiry among the surgical staff of the hospital revealed that the
incidence of benzoin dermatitis could not have been considerably greater than
about 1 in 800 or 1,000, and tends to confirm the findings in the 20 "normal" con-
trols. Therefore, it appears unnecessary to advise against the use of compound
tincture of benzoin in surgical dressings even if the combination with adhesive
tape might be more irritating (see Case 2).
The situation is different, however, in patients with skin diseases. An occur-
rence of immediate sensitization in two of ten individuals is extremely high, and
it suggests that compound tincture of benzoin should not be used in patients with
skin disease, particularly with dermatoses of allergic character. Obviously, a
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history of reaction to compound tincture of benzoin, or to its constituents and
related substances, should be sufficient reason for its complete avoidance. Inhala-
tion of the tincture must also be considered as possibly allergenic in sensitized
individuals, even though the actual dermatitis elicited may result simply from
contact of the vapor with the skin.
In cases of so-called adhesive tape dermatitis, consideration must be given to
the possibility that it is not the tape, but the compound tincture of benzoin so
commonly used with it that is responsible for the dermatitis.
SUMMARY
1. Within a relatively short period of time, three cases of acute dermatitis were
observed from compound tincture of benzoin used in combination with adhesive
tape dressings.
2. Tests were carried out on ten control patients with skin diseases, most of
them of allergic character, and two patients were readily sensitized to compound
tincture of benzoin. Similar tests in twenty control patients, without skin disease
or other allergic manifestations, failed to produce a single instance of sensitiza-
tion.
3. An analysis of more detailed patch tests and their correlation with the con-
stituents of compound tincture of benzoin and other balsams makes it appear
probable that volatile oils and/or resins might be responsible for the dermatitis.
4. Compound tincture of benzoin and its constituents should not be used on
the skin of patients with an allergic disease or a history of allergy.
5. In cases of so-called adhesive tape dermatitis, the possibility that the derma-
titis is actually due to compound tincture of benzoin and not to the tape must be
remembered.
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